According to Axsome Therapeutics 's latest financial reports the company's current EPS (TTM) is -$4.28. In 2022 the company made an earnings per share (EPS) of -$4.57 a decrease over its 2021 EPS that were of -$3.47.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.28 | -6.35% |
2022 | -$4.57 | 31.7% |
2021 | -$3.47 | 25.72% |
2020 | -$2.76 | 38% |
2019 | -$2.00 | 75.44% |
2018 | -$1.14 | -11.63% |
2017 | -$1.29 | -9.79% |
2016 | -$1.43 | 100.29% |
2015 | -$0.71 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -49.07% | ๐บ๐ธ USA |